Ergosta-4,6,8(14),22-tetraen-3-one TN1617
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ergosta-4,6,8(14),22-tetraen-3-one has cytotoxic activity against human gastric cancer cell, it can induce G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells, these results would be useful for the further utilization of man
CAS nr:
19254-69-4
Purity:
98%
Molecular Weight:
392,6
SMILES:
CC(C)[C@@H](C)/C=C/[C@@H](C)[C@@H](CC1)[C@@](C)(CC[C@@H]2[C@@]3(C)CC4)C1=C2C=CC3=CC4=O
Formula:
C28H40O
Pathway:
Proteases/Proteasome,Apoptosis,Apoptosis,Apoptosis
Target:
Caspase,Caspase,BCL,p53
